Skip to main content

Advertisement

Log in

Effect of Exclusive Enteral Nutrition on Th17 Cells in Juvenile Rats with Inflammatory Bowel Disease

  • Original Article
  • Published:
Inflammation Aims and scope Submit manuscript

Abstract

The objective was to investigate the effect of exclusive enteral nutrition (EEN) on T helper (Th) 17 cells by observing the effects of EEN on colon and serum interleukin (IL)-17A levels in juvenile inflammatory bowel disease (IBD) rat models and to reveal the potential mechanism of the therapeutic effect of EEN on IBD. ATNBS-induced IBD rat model was established. Feeding Peptison, a type of enteric nutrition (EN) for EEN-IBD group and EEN group, normal feed for IBD model group and control group for six consecutive days. Four groups of juvenile rats were sacrificed on day 7. The pathology of the intestinal mucosa was examined, the expression of IL-17A in serum was detected by ELISA, and the expression of IL-17A in intestinal tissue was detected by both western blot and real-time PCR (RT-PCR). Diarrhea, bloody stools, and weight loss were found in both the IBD group and the EEN-IBD group. After 5 days of EEN feeding, the stool characteristics, and blood in the stools of the rats in the EEN-IBD group were significantly relieved compared with those of the IBD group. There was no significant difference in the body mass growth rate between the IBD group and EEN-IBD group (P > 0.05). The growth rate of the EEN group was 51.29 ± 3.61%, which was significantly lower than that of the control group (60.17 ± 9.32%) with P < 0.05. The disease activity index (DAI) score of the EEN-IBD group was significantly lower than that of the IBD group (P < 0.05). In the IBD group, colonic congestion and edema were obvious, scattered ulcers were observed, and the intestinal mucosa had a large amount of inflammatory cell infiltration. In the EEN-IBD group, the intestinal mucosa was slightly congested and a small amount of inflammatory cell infiltrated. The serum IL-17A expression level in the IBD group was significantly higher than in the EEN-IBD group, control group, and EEN group (P < 0.05). Both the gene and protein expressions of IL-17A in the intestinal tissue of the EEN-IBD group were significantly lower than in the IBD group (P < 0.01), and it was significantly higher in the IBD group than in the control and EEN groups (P < 0.01). EEN effectively reduced the intestinal inflammation in the juvenile rats with IBD. The mechanism could be related to the regulation of Th17 cells and the expression of the corresponding cytokine, IL-17A. EEN may play a role in downregulating the expression of IL-17A in the intestinal mucosa.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

REFERENCES

  1. Meijer, B., C.J. Mulder, G.J. Peters, A.A. van Bodegraven, and N.K. de Boer. 2016. Efficacy of thioguanine treatment in inflammatory bowel disease: a systematic review. World Journal of Gastroenterology 22: 9012–9021.

    CAS  PubMed  PubMed Central  Google Scholar 

  2. Gasparetto, Marco, and Graziella Guariso. 2013. Highlights in IBD epidemiology and its natural history in the paediatric age. Gastroenterology Research and Practice 2013: 829040.

    PubMed  PubMed Central  Google Scholar 

  3. Wang, X.Q., Y. Zhang, C.D. Xu, L.R. Jiang, Y. Huang, H.M. Du, and X.J. Wang. 2013. Inflammatory bowel disease in Chinese children: a multicenter analysis over a decade from Shanghai. Inflammatory Bowel Diseases 19: 423–428.

    PubMed  Google Scholar 

  4. Ramos, G.P., and K.A. Papadakis. 2019. Mechanisms of Disease: Inflammatory Bowel Diseases. Mayo Clinic Proceedings 94: 155–165.

    CAS  PubMed  PubMed Central  Google Scholar 

  5. Globig, A.M., N. Hennecke, B. Martin, M. Seidl, G. Ruf, P. Hasselblatt, R. Thimme, and B. Bengsch. 2014. Comprehensive intestinal T helper cell profiling reveals specific accumulation of IFN-γ+IL-17+ coproducing CD4+ T cells in active inflammatory bowel disease. Inflammatory Bowel Diseases 20: 2321–2329.

    PubMed  Google Scholar 

  6. Brand, S. 2009. Crohn’s disease: Th1, Th17 or both? The change of a paradigm: new immunological and genetic insights implicate Th17cells in the pathogenesis of Crohn’s disease. Gut 58: 1152–1167.

    CAS  PubMed  Google Scholar 

  7. Tani, S., R. Takano, S. Tamura, S. Oishi, M. Iwaizumi, Y. Hamaya, K. Takagaki, T. Nagata, S. Seto, T. Horii, I. Kosugi, T. Iwashita, S. Osawa, T. Furuta, H. Miyajima, and K. Sugimoto. 2017. Digoxin attenuates murine experimental colitis by downregulating Th17-related cytokines. Inflammatory Bowel Diseases 23: 728–738.

    PubMed  Google Scholar 

  8. Guariso, G., M. Gasparetto, L. Visona Dalla Pozza, R. D’Incà, L. Zancan, G. Sturniolo, F. Brotto, and P. Facchin. 2010. Inflammatory bowel disease developing in paediatric and adult age. Journal of Pediatric Gastroenterology and Nutrition 5l (6): 698–707.

    Google Scholar 

  9. Hamamoto, N., K. Maemura, I. Hirata, M. Murano, S. Sasaki, and K. Katsu. 1999. Inhibition of dextran sulphate sodium (DSS)-induced colitis in mice by intracolonically administered antibodies against adhesion molecules (endothelial leucocyte adhesion molecule-1(ELAM- 1) or intercellular adhesion molecule-1(ICAM-1)). Clinical and Experimental Immunology 117: 462–468.

    CAS  PubMed  PubMed Central  Google Scholar 

  10. Hundorfean, G., M.F. Neurath, and J. Mudter. 2012. Functional relevance of T helper 17 (Th17) cells and the IL-17cytokine family in inflammatory bowel disease. Inflammatory Bowel Diseases 18: 180–186.

    PubMed  Google Scholar 

  11. van den Brink, G., L. Stapersma, L.E. Vlug, D. Rizopolous, A.G. Bodelier, H. van Wering, P.C.W.M. Hurkmans, R.J.L. Stuyt, D.M. Hendriks, J.A.T. van der Burg, E.M.W.J. Utens, and J.C. Escher. 2018. Clinical disease activity is associated with anxiety and depressive symptoms in adolescents and young adults with inflammatory bowel disease. Alimentary Pharmacology & Therapeutics 48: 358–369.

    Google Scholar 

  12. Neurath, M.F., and S.P. Travis. 2012. Mucosal healing in inflammatory bowel diseases: a systematic review. Gut 61: 1619–1635.

    CAS  PubMed  Google Scholar 

  13. Michail, S., M. Ramsy, and E. Soliman. 2012. Advances in inflammatory bowel diseases in children. Minerva Pediatrica 64 (3): 257–270.

    CAS  PubMed  Google Scholar 

  14. Chinese Society of Gastroenterology inflammatory bowel disease group. 2015. Consensus among nutritional support therapists for inflammatory bowel disease (2013·Shenzhen). Chinese Journal of Gastrointestinal Surgery 20: 97–105.

    Google Scholar 

  15. Yu, Y., K.C. Chen, and J. Chen. 2019. Exclusive enteral nutrition versus corticosteroids for treatment of pediatric Crohn’s disease: a meta-analysis. World Journal of Pediatrics 15: 26–36.

    CAS  PubMed  PubMed Central  Google Scholar 

  16. Chinese Society for Parenteral and Enteral Nutrition, Chinese Society of Gastroenterology inflammatory bowel disease group. 2013. Consensus on nutritional support therapy for inflammatory bowel disease. Chinese Journal of Integrative Medicine 52: 1082–1087.

    Google Scholar 

  17. Ungaro, R., S. Mehandru, P.B. Allen, L. Peyrin-Biroulet, and J.F. Colombel. 2017. Ulcerative colitis. Lance 389: 1756–1770.

    Google Scholar 

  18. Kmieć, Z., M. Cyman, and T.J. Ślebioda. 2017. Cells of the innate and adaptive immunity and their interactions in inflammatory bowel disease. Advances in Medical Sciences 62: 1–16.

    PubMed  Google Scholar 

  19. Khan, D., and Ahmed S. Ansar. 2015. Regulation of IL-17 in autoimmune diseases by transcriptional factors and microRNAs. Frontiers in Genetics 6: 236.

    PubMed  PubMed Central  Google Scholar 

  20. Fujino, S., A. Andoh, S. Bamba, A. Ogawa, K. Hata, Y. Araki, T. Bamba, and Y. Fujiyama. 2003. Increased expression of interleukin 17 in inflammatory bowel disease. Gut 52: 65–70.

    CAS  PubMed  PubMed Central  Google Scholar 

  21. Li, L., Q.G. Shi, F. Lin, Y.G. Liang, L.J. Sun, J.S. Mu, Y.G. Wang, H.B. Su, B. Xu, C.C. Ji, et al. 2014. Cytokine IL-6 is required in Citrobacter rodentium infection induced intestinal Th17 responses and promotes IL-22 expression in inflammatory bowel disease. Molecular Medicine Reports 9: 831–836.

    CAS  PubMed  Google Scholar 

  22. Rubio, A., B. Pigneur, H. Gamier-Lengling, C. Talbotec, J. Schmitz, D. Canioni, O. Goulet, and F.M. Ruemmele. 2011. The efficacy of exclusive nutritional therapy in paediatric Crohn’s disease, comparing fractionated oral vs. continuous enteral feeding. Alimentary Pharmacology & Therapeutics 33: 1332–1339.

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jie Wu.

Ethics declarations

Conflict of Interest

The authors declare that they have no conflict of interest.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Teng, X., Qi, Y., Li, J. et al. Effect of Exclusive Enteral Nutrition on Th17 Cells in Juvenile Rats with Inflammatory Bowel Disease. Inflammation 44, 261–269 (2021). https://doi.org/10.1007/s10753-020-01328-4

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10753-020-01328-4

KEY WORDS

Navigation